← Leaderboards
John E Conte
University Of California San Francisco
$521,293
Attributed
$521,293
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$521,293 · 5
By mechanism
M01$521,293 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Homer A Boushey$9,020,633
- Jay H Tureen$73,006
- Warren Winkelstein$564
- Bertram Harold Lubin$7,666,702
- Leslie Z Benet$3,583,449
Others in their field
Top investigators on “Bronchoscopy”
- Prescott G Woodruff · University Of California San Francisco$32,092,874
- Ronald G Crystal · Weill Medical College Of Cornell Univ$13,844,162
- John V Fahy · University Of California San Francisco$9,453,184
- Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr$8,758,202
- Laurence Huang · University Of California San Francisco$8,606,875
- Eugene R Bleecker · University Of California, San Diego$8,218,112
Research focus
BronchoscopyClinical ResearchPharmacokineticsHuman SubjectDiagnostic Respiratory LavageIsoniazidHiv InfectionsBlood ChemistryRifamycinsPyrazinamideHuman Therapy EvaluationDosageRespiratory Disorder ChemotherapyAidsAids TherapyCombination ChemotherapyDrug Screening /EvaluationMicroorganism Disease ChemotherapyOral AdministrationPlasmaRespiratory PharmacologyPhlebotomyTuberculosisEthambutol
Grant awards (13)
PHARMACOKINETIC/PHARMACODYNAMIC STUDY OF LEVOFLOXACIN IN HEALTHY VOLUNTEERS AND$50,973
M01 · FY2005 · RR
Steady State Intrapulmonary Pharmacokinetics of Tigecycline in Healthy Adults$157,894
M01 · FY2004 · RR
Meropenem Intrapulmonary &Plasma Pharmacokinetics in Healthy Adults$16,428
M01 · FY2004 · RR
Intrapulmonary Concentrations of Steady State Itraconazole$11,865
M01 · FY2004 · RR
Kinetics of INH in AIDS$9,469
M01 · FY2004 · RR
PHARMACOKINETICS OF ANTITUBERCULOUS AGENTS IN HIV INFECTION$68,666
M01 · FY2002 · RR
TUBERCULOSIS AND AIDS$68,666
M01 · FY2002 · RR
TUBERCULOSIS AND AIDS$68,666
M01 · FY2001 · RR
PHARMACOKINETICS OF ANTITUBERCULOUS AGENTS IN HIV INFECTION$68,666
M01 · FY2001 · RR
TUBERCULOSIS AND AIDS$0
M01 · FY2001 · RR
PHARMACOKINETICS OF ANTITUBERCULOUS AGENTS IN HIV INFECTION$0
M01 · FY2001 · RR
TUBERCULOSIS AND AIDS$0
M01 · FY2000 · RR
PHARMACOKINETICS OF ANTITUBERCULOUS AGENTS IN HIV INFECTION$0
M01 · FY2000 · RR